Department of Health and Human Services June 22, 2007 – Federal Register Recent Federal Regulation Documents

Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Infant Formula Requirements
Document Number: E7-12057
Type: Notice
Date: 2007-06-22
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is announcing that a collection of information entitled ``Infant Formula Requirements'' has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.
Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Guidance for Industry on Special Protocol Assessment
Document Number: E7-12056
Type: Notice
Date: 2007-06-22
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.
Agency Information Collection Activities: Submission for OMB Review; Comment Request
Document Number: E7-12054
Type: Notice
Date: 2007-06-22
Agency: Centers for Medicare & Medicaid Services, Department of Health and Human Services
Medicare Program; Meeting of the Medicare Evidence Development & Coverage Advisory Committee-(MedCAC)
Document Number: E7-12046
Type: Notice
Date: 2007-06-22
Agency: Centers for Medicare & Medicaid Services, Department of Health and Human Services
This notice announces a public meeting of the Medicare Evidence Development and Coverage Advisory Committee (MedCAC) (Committee). Among other things, the Committee provides advice and recommendations about whether scientific evidence is adequate to determine whether certain medical items and services are reasonable and necessary under the Medicare statute. This meeting will consider the evidence on the diagnostic criteria for obstructive sleep apnea (OSA) in Medicare beneficiaries who may be candidates for continuous positive airway pressure (CPAP) therapy and alternatives to facility-based polysomnography (PSG) in the diagnosis of OSA, including home sleep testing devices and clinical diagnosis without the use of sleep testing. This meeting is given under the Federal Advisory Committee Act (5 U.S.C. App. 2, section 10(a)).
Agency Information Collection Activities: Proposed Collection; Comment Request
Document Number: E7-12043
Type: Notice
Date: 2007-06-22
Agency: Centers for Medicare & Medicaid Services, Department of Health and Human Services
Medicare Program; Provider Reimbursement Determinations and Appeals; Extension of Timeline for Publication of Final Rule
Document Number: E7-11721
Type: Proposed Rule
Date: 2007-06-22
Agency: Centers for Medicare & Medicaid Services, Department of Health and Human Services
Section 1871(a)(3)(A) of the Social Security Act (the Act) requires us to publish a Medicare final rule no later than 3 years after the publication date of the proposed rule. This notice announces an extension of the timeline for publication of a Medicare final rule in accordance with section 1871(a)(3)(B) of the Act, which allows us to extend the timeline for publication of final rules under exceptional circumstances.
Medicare and Medicaid Programs; Quarterly Listing of Program Issuances-January Through March 2007
Document Number: 07-2918
Type: Notice
Date: 2007-06-22
Agency: Centers for Medicare & Medicaid Services, Department of Health and Human Services
This notice lists CMS manual instructions, substantive and interpretive regulations, and other Federal Register notices that were published from January 2007 through March 2007, relating to the Medicare and Medicaid programs. This notice provides information on national coverage determinations (NCDs) affecting specific medical and health care services under Medicare. Additionally, this notice identifies certain devices with investigational device exemption (IDE) numbers approved by the Food and Drug Administration (FDA) that potentially may be covered under Medicare. This notice also includes listings of all approval numbers from the Office of Management and Budget for collections of information in CMS regulations and a list of Medicare-approved carotid stent facilities. Included in this notice is a list of the American College of Cardiology's National Cardiovascular Data registry sites, active CMS coverage-related guidance documents, and special one-time notices regarding national coverage provisions. Also included in this notice is a list of National Oncologic Positron Emissions Tomography Registry sites, a list of Medicare-approved ventricular assist device (destination therapy) facilities, a list of Medicare-approved lung volume reduction surgery facilities, a list of Medicare-approved clinical trials for fluorodeoxyglucose positron emissions tomography for dementia, and a list of Medicare-approved bariatric surgery facilities. Section 1871(c) of the Social Security Act requires that we publish a list of Medicare issuances in the Federal Register at least every 3 months. Although we are not mandated to do so by statute, for the sake of completeness of the listing, and to foster more open and transparent collaboration efforts, we are also including all Medicaid issuances and Medicare and Medicaid substantive and interpretive regulations (proposed and final) published during this 3-month time frame.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.